Page 219 - Read Online
P. 219

Riojas et al. Vessel Plus 2024;8:6  https://dx.doi.org/10.20517/2574-1209.2023.122  Page 15 of 16

               5.       Metkus TS, Beckie TM, Cohen MG, et al. The heart team for coronary revascularization decisions: 2 illustrative cases. JACC Case
                   Rep 2022;4:115-20.  DOI  PubMed  PMC
               6.       Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve
                   replacement. J Am Coll Cardiol 2012;59:1200-54.  DOI
               7.       Doll JA, Ohman EM, Patel MR, et al. A team-based approach to patients in cardiogenic shock. Catheter Cardiovasc Interv
                   2016;88:424-33.  DOI
               8.       Bloomer TL, Thomassee EJ, Fong PP. Acute pulmonary embolism network and multidisciplinary response team approach to
                   treatment. Crit Pathw Cardiol 2015;14:90-6.  DOI
               9.       Luckraz H, Norell M, Buch M, James R, Cooper G. Structure and functioning of a multidisciplinary “heart team” for patients with
                   coronary artery disease: rationale and recommendations from a joint BCS/BCIS/SCTS working group. Eur J Cardiothorac Surg
                   2015;48:524-9.  DOI
               10.      Blankenship JC, Patel K. High rates of ad hoc PCI may mandate a modified heart team approach. JACC Cardiovasc Interv
                   2023;16:1743-5.  DOI
               11.      Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial
                   revascularization of the european society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS).
                   Developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI). Eur J
                   Cardiothorac Surg 2014;46:517-92.  DOI
               12.      Faridi KF, Rymer JA, Rao SV, et al. Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: a
                   report from the national cardiovascular data registry cathPCI registry. Am Heart J 2019;216:53-61.  DOI
               13.      Hannan EL, Samadashvili Z, Walford G, et al. Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary
                   interventions. JACC Cardiovasc Interv 2009;2:350-6.  DOI
               14.      Hannan EL, Zhong Y, Cozzens K, et al. Ad hoc percutaneous coronary intervention in stable patients with multivessel or unprotected
                   left main disease. JACC Cardiovasc Interv 2023;16:1733-42.  DOI  PubMed
               15.      Vander Salm TJ, Kip KE, Jones RH, et al. What constitutes optimal surgical revascularization? : Answers from the bypass
                   angioplasty revascularization investigation (BARI)J Am Coll Cardiol 2002;39:565-72. DOI
               16.      Gaba P, Gersh BJ, Ali ZA, Moses JW, Stone GW. Complete versus incomplete coronary revascularization: definitions, assessment and
                   outcomes. Nat Rev Cardiol 2021;18:155-68.  DOI  PubMed
               17.      Yanagawa B, Puskas JD, Bhatt DL, Verma S. The coronary heart team. Curr Opin Cardiol 2017;32:627-32.  DOI  PubMed
               18.      Sanchez CE, Badhwar V, Dota A, et al. Practical implementation of the coronary revascularization heart team. Circ Cardiovasc Qual
                   Outcomes 2013;6:598-603.  DOI
               19.      Pavlidis AN, Perera D, Karamasis GV, et al. Implementation and consistency of heart team decision-making in complex coronary
                   revascularisation. Int J Cardiol 2016;206:37-41.  DOI
               20.      Rocha RV, Wang X, Fremes SE, et al. Variations in coronary revascularization practices and their effect on long-term outcomes. J Am
                   Heart Assoc 2022;11:e022770.  DOI  PubMed  PMC
               21.      King III SB, Barnhart HX, Kosinski AS, et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible
                   registry and randomized patients in the EAST Trial and influence of treatment selection on outcomes. Emory angioplasty versus
                   surgery trial investigators. Am J Cardiol 1997;79:1453-9.  DOI
               22.      Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with
                   bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037-43.  DOI  PubMed
               23.      Feit F, Brooks MM, Sopko G, et al. Long-term clinical outcome in the bypass angioplasty revascularization investigation registry.
                   Comparison with the randomized trial. Circulation 2000;101:2795-802.  DOI
               24.      BARI Investigators. The BARI protocol. Protocol for the bypass angioplasty revascularization investigation. Circulation 1991;84[suppl
                   V]:V-1-27.Avaliable from: https://biolincc.nhlbi.nih.gov/media/studies/bari/Protocol.pdf?link_time=2019-12-02_01:21:53.397374
                   [Last accessed on 19 Jan 2024].
               25.     The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for
                   Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010;38:S1-52.  DOI
               26.      Yamasaki M, Abe K, Horikoshi R, et al. Enhanced outcomes for coronary artery disease obtained by a multidisciplinary heart team
                   approach. Gen Thorac Cardiovasc Surg 2019;67:841-8.  DOI
               27.      Papolos AI, Kenigsberg BB, Berg DD, et al; Critical Care Cardiology Trials Network Investigators. Management and outcomes of
                   cardiogenic shock in cardiac ICUs with versus without shock teams. J Am Coll Cardiol 2021;78:1309-17.  DOI
               28.      Holmes DR Jr, Rich JB, Zoghbi WA, Mack MJ. The heart team of cardiovascular care. J Am Coll Cardiol 2013;61:903-7.  DOI
               29.      Young MN, Kolte D, Cadigan ME, et al. Multidisciplinary heart team approach for complex coronary artery disease: single center
                   clinical presentation. J Am Heart Assoc 2020;9:e014738.  DOI  PubMed  PMC
               30.      Campos CM, Stanetic BM, Farooq V, et al; SYNTAX II Study Group. Risk stratification in 3-vessel coronary artery disease: applying
                   the SYNTAX score II in the heart team discussion of the SYNTAX II trial. Catheter Cardiovasc Interv 2015;86:E229-38.  DOI
               31.      Ma H, Lin S, Li X, Wang Y, Xu B, Zheng Z. Effect of a standardised heart team protocol versus a guideline-based protocol on
                   revascularisation decision stability in stable complex coronary artery disease: rationale and design of a randomised trial of cardiology
                   specialists using historic cases. BMJ Open 2022;12:e064761.  DOI  PubMed  PMC
               32.      Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for
                   coronary revascularization focused update: a report of the American college of cardiology foundation appropriate use criteria task
                   force, society for cardiovascular angiography and interventions, society of thoracic surgeons, American association for thoracic
   214   215   216   217   218   219   220   221   222   223   224